Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-10-28

FDA Approved: DICLOFENAC SODIUM — Original Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved Amneal's Original Application for Diclofenac Sodium Tablets, a generic NSAID indicated for relief of pain and inflammation in several conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac Sodium Tablets (diclofenac sodium)

Snippet

ORIG AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM)